A Study to Investigate the Potential Pharmacokinetic Interaction of Perampanel With Oral Contraceptives in Healthy Female Subjects

NCT01209858 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Onset Epilepsy

Interventions

DRUG: Perampanel and Microgynon-30
DRUG: Perampanel and Microgynon-30

Sponsor

Eisai Inc.